Biocon Biologics Gets EMA Nod for Bevacizumab Production
June 24, 2024 11:24
Biocon Biologics receives approval from the EMA to manufacture biosimilar Bevacizumab at its Bengaluru facility, expanding capacity for European markets. The company also received GMP certificates...